MicroRNA-21 inhibits SMAD7 expression through a target sequence in the 3′ untranslated region and inhibits proliferation of renal tubular epithelial cells

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 707-712

  Lin, Li ^a   Gan, Hua ^a   Zhang, Han ^a   Tang, Weixue ^a   Sun, Yue ^a   Tang, Xueqin ^a   Kong, Dequan ^a   Zhou, Jiajun ^b   Wang, Yuxuan ^a   Zhu, Yanlin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

Author keywords

microRNA; microRNA 21; Renal tubular epithelial cell; SMAD7

Indexed keywords

MICRORNA 21; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; 3' UNTRANSLATED REGION; MICRORNA; MIRN21 MICRORNA, RAT;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; EPITHELIUM CELL; GENE VECTOR; GENETICS; KIDNEY TUBULE; LENTIVIRINAE; METABOLISM; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; GENETIC VECTORS; HEK293 CELLS; HUMANS; KIDNEY TUBULES; LENTIVIRUS; MICRORNAS; RATS; SEQUENCE ALIGNMENT; SMAD7 PROTEIN;

EID: 84903266446     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2312     Document Type: Article

References (30)

1. Baek D, Villén J, Shin C, et al: The impact of microRNAs on protein output. Nature 455: 64-71, 2008.
2. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
3. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
4. Eulalio A, Huntzinger E and Izaurralde E: Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14, 2008.
5. Calin GA, Dumitru CD, Shimizu M, Bichi R, et al: Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002. (Pubitemid 35403967)
6. Calin GA, Ferracin M, Cimmino A, Di Leva G, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
7. Michael MZ, O'Conner SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003. (Pubitemid 37288707)
8. Pfeffer S, Zavolan M, Grasser FA, Chien M, et al: Identification of virus-encoded microRNAs. Science 304: 734-736, 2004. (Pubitemid 38560879)
9. Hwang H and Mendell J: MicroRNAs in cell proliferation, cell death and tumorigenesis. Br J Cancer 94: 776-780, 2006.
10. Chen C, Li L, Lodish H and Bartel D: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004. (Pubitemid 38055775)
11. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an anti apoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005. (Pubitemid 40994386)
12. Yanaihara N, Caplen N, Bowman E, Seike M, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
13. Markou A, Tsaroucha EG, Kaklamanis L, et al: Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54: 1696-1704, 2008.
14. Volinia S, Calin GA, Liu CG, Ambs S, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
15. Slaby O, Svoboda M, Fabian P, Smerdova T, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007. (Pubitemid 351238155)
16. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colonadenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
17. Meng F, Henson R, Lang M, Wehbe H, et al: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129, 2006. (Pubitemid 43816961)
18. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P and Hatzigeorgiou AG: The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 37: D155-D158, 2009.
19. Selcuklu SD, Donoghue MT, and Spillane C: miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37: 918-925, 2009.
20. Ashcroft GS, Yang X, Glick AB, Weinstein M, et al: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1: 260-266, 1999. (Pubitemid 129495775)
21. Attisano L, Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 12: 235-243, 2000. (Pubitemid 30142572)
22. Attisano L, Wrana JL: Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647, 2002.
23. Hayashi H, Abdollah S, Qiu Y, et al: The SMAD-related protein SMAD7 associates with the TGF beta receptor and functions as an antagonist of TGF beta signaling. Cell 89: 1165-1173, 1997. (Pubitemid 127678749)
24. Kavsak P, Rasmussen RK, Causing CG, et al: SMAD7 binds to Smurf 2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375, 2000. (Pubitemid 32045929)
25. Karp X, Ambros V: Encountering microRNAs in cell fate signaling. Science 310: 1288-1289, 2005. (Pubitemid 41698853)
26. Chen CZ, Li L, Lodish HF and Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004. (Pubitemid 38055775)
27. Heldin CH, Miyazono K and ten Dijke P: TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997. (Pubitemid 28013118)
28. Massague J and Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754, 2000. (Pubitemid 30204386)
29. Zhu H, Li Y, Qu S, et al: MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 32: 514-522, 2012.
30. Wei J, Feng L, Li Z, Xu G and Fan X: MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Biomed Pharmacother 67: 387-392, 2013.